Acurx Pharmaceuticals Ownership | Who Owns Acurx Pharmaceuticals?


OverviewFinancialsChartTranscripts

Acurx Pharmaceuticals Ownership Summary


Acurx Pharmaceuticals is owned by 6.69% institutional investors, 2.99% insiders, and 90.32% retail investors. Jane street group is the largest institutional shareholder, holding 2.01% of ACXP shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.97% of its assets in Acurx Pharmaceuticals shares.

ACXP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAcurx Pharmaceuticals6.69%2.99%90.32%
SectorHealthcare Stocks 35.49%11.75%52.76%
IndustryBiotech Stocks 34.83%11.71%53.46%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Jane street group54.64K2.01%$202.72K
Geode capital management24.82K0.91%$92.08K
Cambridge investment research advisors20.00K0.74%$74.00K
Vanguard fiduciary trust16.20K0.60%$60.12K
Prospect financial services13.79K0.51%$51.14K
Susquehanna group, llp48.37K0.30%$39.38K
Morgan stanley6.50K0.24%$24.11K
Ubs group6.31K0.23%$23.42K
Blackrock27.50K0.18%$61.88K
Wells fargo & company/mn2.30K0.08%$8.53K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Prospect financial services13.79K0.03%$51.14K
Semmax financial advisors5.88K0.00%$11.17K
Westside investment management1.65K0.00%$6.12K
Nbc securities1.50K0.00%$5.57K
Cambridge investment research advisors20.00K0.00%$74.00K
Tower research capital llc (trc)1.03K0.00%$3.83K
Blackrock27.50K-$61.88K
Renaissance---
Geode capital management24.82K-$92.08K
Act advisors, llc.---

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp48.37K-48.37K
Jane street group54.64K-43.90K
Cambridge investment research advisors20.00K0.00%20.00K
Vanguard fiduciary trust16.20K-16.20K
Geode capital management24.82K-12.40K

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.08M
Vanguard group---145.54K
Renaissance---87.78K
Sabby management---81.89K
O'brien greene---60.00K

New Positions

HolderShares% AssetsChangeValue
Susquehanna group, llp48.37K-48.37K$39.38K
Cambridge investment research advisors20.00K0.00%20.00K$74.00K
Vanguard fiduciary trust16.20K-16.20K$60.12K
Westside investment management1.65K0.00%1.65K$6.12K
Barclays380.00-380.00$1.41K

Sold Out

HolderChange
Jpmorgan chase-29.00
Northwestern mutual wealth management-1.64K
Simplex trading-6.89K
Tocqueville asset management-10.00K
Quartz partners-10.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20262116.67%181,86131.20%67.82%10-4-20.00%
Dec 31, 20251812.50%138,609119.55%961.32%10150.00%5-58.33%
Sep 30, 20251-96.67%7,582-99.70%-0.58%--100.00%1-85.71%
Jun 30, 20253350.00%2,610,04879.65%1020.86%1990.00%740.00%
Mar 31, 202523-17.86%3,497,399146.63%1723.24%11-21.43%525.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF384.36K1.97%551.00
Vanguard Total Stock Mkt Idx Inv383.81K1.63%-
Vanguard Institutional Extnd Mkt Idx Tr31.10K1.09%24.02K
Fidelity Extended Market Index16.31K0.38%4.82K
iShares Micro-Cap ETF27.76K0.12%-
NT Ext Equity Mkt Idx Fd - L2.77K0.10%-13.73K
Spartan Extended Market Index Pool E15.76K0.08%650.00
Spartan Extended Market Index Pool F3.32K0.08%3.32K
Fidelity Series Total Market Index2.98K0.07%1.99K
Northern Trust Extended Eq Market Idx2.77K0.06%1.82K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 06, 2025Scodari Joseph C-Buy$25.00K
Jan 06, 2025Scodari Joseph C-Buy$22.17K
Jan 06, 2025Sailer Carl-Buy$25.00K
Jan 06, 2025Sailer Carl-Buy$22.17K
Jan 06, 2025LUCI DAVID P President and CEOBuy$50.00K

Insider Transactions Trends


DateBuySell
2026 Q2--
2025 Q112-
2024 Q2--
2024 Q1--
2023 Q4--

ACXP Ownership FAQ


Who Owns Acurx Pharmaceuticals?

Acurx Pharmaceuticals shareholders are primarily institutional investors at 6.69%, followed by 2.99% insiders and 90.32% retail investors. The average institutional ownership in Acurx Pharmaceuticals's industry, Biotech Stocks , is 34.83%, which Acurx Pharmaceuticals falls below.

Who owns the most shares of Acurx Pharmaceuticals?

Acurx Pharmaceuticals’s largest shareholders are Jane street group (54.64K shares, 2.01%), Geode capital management (24.82K shares, 0.91%), and Cambridge investment research advisors (20K shares, 0.74%). Together, they hold 3.66% of Acurx Pharmaceuticals’s total shares outstanding.

Does Blackrock own Acurx Pharmaceuticals?

Yes, BlackRock owns 0.18% of Acurx Pharmaceuticals, totaling 27.5K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 61.88K$. In the last quarter, BlackRock increased its holdings by 8.82K shares, a 47.17% change.

Who is Acurx Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Prospect financial services is Acurx Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 13.78K Acurx Pharmaceuticals shares, valued at 51.14K$.

Who is the top mutual fund holder of Acurx Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Acurx Pharmaceuticals shares, with 1.97% of its total shares outstanding invested in 384.36K Acurx Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools